Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA/RxHealth

Executive Summary

September meeting between Pharmaceutical Research & Manufacturers of America health outcomes committee and the RxHealth Value coalition was a general get acquainted session, PhRMA said. The pharmaceutical trade association has no plans to provide information to RxHealth for specific outcomes studies. RxHealth Value Executive Director John Golenski mentioned the meeting with PhRMA during a National Institute for Health Care Management conference Sept. 25 (1"The Pink Sheet" Oct. 16, p. 11)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS036789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel